Research suggests that Tribulus terrestris and certain compounds derived from it may support blood sugar regulation through several biological mechanisms, based on early-stage preclinical evidence. Studies indicate that a whole plant extract reduced blood glucose and protected kidney function in diabetic rats by activating the protective Nrf-2 pathway and suppressing inflammatory signaling, while a separate study found that xanthosine, a compound naturally present in the plant, corrected abnormal liver glucose production in both cell cultures and diabetic rats by activating the energy-sensing protein AMPK. Both studies are limited to animal and cell-based models, with no human clinical trials represented in this evidence base, which substantially limits conclusions about how these findings might translate to people. The overall direction of the available research is supportive of a potential role in blood sugar management, but the evidence is too preliminary to draw firm conclusions, and further research including human trials would be needed to evaluate real-world relevance.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Tribulus terrestris L. extract alleviates diabetic nephropathy through regula... | Other | 2026 | Supports | 72 |
| Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through i... | Other | 2023 | Supports | 67 |